In the US, Hizentra (immune globulin subcutaneous systemic) is a member of the drug class immune globulins and is used to treat Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Primary Immunodeficiency Syndrome.
Ingredient matches for Hizentra
Human Normal Immune Globulin is reported as an ingredient of Hizentra in the following countries:
- Czech Republic
- United Kingdom
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.